Cesar Gentille

Researcher

Last publication 2026 Last refreshed 2026-05-16

unknown

1 h-index 8 pubs 12 cited

Biography and Research Information

OverviewAI-generated summary

Cesar Gentille's research focuses on the clinical outcomes and treatment strategies for patients with hematologic malignancies, particularly multiple myeloma and lymphoma. His work investigates the efficacy of novel immunotherapies, including CAR-T cell therapy and bispecific T-cell engagers, in relapsed or refractory disease settings. Gentille has published studies examining opportunistic infections in patients undergoing daratumumab regimens for multiple myeloma and the association between specific immune responses, such as cytokine release syndrome, and adverse cardiac events following CAR-T therapy. He also explores outcomes for treatments like mogamulizumab in Sézary syndrome. Gentille collaborates with researchers at the University of Arkansas for Medical Sciences, including Toshali Pandey, Curran Henson, Grant M. Spears, and Bhavesh Mohan Lal, with whom he has co-authored publications.

Metrics

  • h-index: 1
  • Publications: 8
  • Citations: 12

Selected Publications

  • Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report (2026)
  • Real-World Survival Outcomes of CAR-T and Bispecific T-cell Engagers in Patients with relapsed/refractory DLBCL (2026)
  • Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome (2025)

View all publications on OpenAlex →

Collaboration Network

51 Collaborators 9 Institutions 1 Country

Top Collaborators

Similar Researchers

Based on overlapping research topics